Dec 19, 2025 06:17AM Canaccord Genuity Reiterates Buy Rating on Fractyl Health Inc (GUTS)

Dec 3, 2025 06:23AM Canaccord Genuity Reiterates Buy Rating on Fractyl Health Inc (GUTS)

Dec 2, 2025 07:02AM Fractyl Health reports weight maintenance data from Revita procedure study

Nov 21, 2025 06:47AM Fractyl Health Inc (GUTS) PT Raised to $8 at Canaccord Genuity

Oct 7, 2025 07:02AM Fractyl Health reports weight loss results from obesity gene therapy

Sep 29, 2025 06:57AM Fractyl Health Inc (GUTS) PT Lowered to $8 at H.C. Wainwright

Sep 26, 2025 07:00AM Fractyl Health reports weight maintenance results after GLP-1 discontinuation

Sep 15, 2025 06:05AM H.C. Wainwright Starts Fractyl Health Inc (GUTS) at Buy

Aug 28, 2025 06:51AM Ladenburg Thalmann Starts Fractyl Health Inc (GUTS) at Buy

Aug 14, 2025 06:43AM Fractyl Health Inc (GUTS) PT Lowered to $6 at Canaccord Genuity

Aug 5, 2025 04:04PM Fractyl Health reports two-year weight loss data from German study

Jul 18, 2025 06:21AM Canaccord Genuity Reiterates Buy Rating on Fractyl Health Inc (GUTS)

Jun 24, 2025 07:08AM Canaccord Genuity Reiterates Buy Rating on Fractyl Health Inc (GUTS)

Jun 23, 2025 11:35AM Evercore ISI Reiterates Outperform Rating on Fractyl Health Inc (GUTS)

Jun 23, 2025 07:41AM Fractyl Health (GUTS) Reports Positive 3-Month REVEAL-1 Cohort Data Showing Revita Sustained Weight Loss After GLP-1 Discontinuation

Jun 18, 2025 07:03AM Fractyl Health (GUTS) Reinforces Intellectual Property Leadership in Metabolic Disease with Two New U.S. Patents Directed to Duodenal Resurfacing

May 19, 2025 07:08AM Fractyl Health (GUTS) Advances Rejuva Gene Therapy Platform with Submission of First Clinical Trial Application Module in Europe for RJVA-001 in Type 2 Diabetes

Mar 3, 2025 04:27PM Fractyl Health, Inc. (GUTS) Misses Q4 EPS by 10c

Jul 30, 2024 07:02AM Fractyl Health (GUTS) Receives FDA Breakthrough Device Designation for Revita